Walden University NURS 6630 – Psychopharmacologic Approaches to Treatment of Psychopathology; Week. 3 Case Study 29. The depressed man who thought he was out of options. Graded A.

Document Content and Description Below

Walden University NURS 6630 – Psychopharmacologic Approaches to Treatment of Psychopathology; Week. 3 Case Study 29. The depressed man who thought he was out of options. Graded A. Walden University... NURS 6630 – Psychopharmacologic Approaches to Treatment of Psychopathology List three questions you might ask the patient if he or she were in your office. Provide a rationale for why you might ask these questions. Identify people in the patient's life you would need to speak to or get feedback from to assess the patient's situation further. Include specific questions you might ask these people and why. Explain what physical exams and diagnostic tests would be appropriate for the patient and how the results would be used. List three differential diagnoses for the patient. Identify the one that you think is most likely and explain why. List two pharmacologic agents and their dosing that would be appropriate for the patient's antidepressant therapy based on pharmacokinetics and pharmacodynamics. From a mechanism of action perspective, provide a rationale for why you might choose one agent over the other. For the drug therapy, you select, identify any contraindications to use or alterations in dosing that may need to be considered based on the client's ethnicity. Discuss why the contraindication/alteration you identify exists. That is, what would be problematic with the use of this drug in individuals of other ethnicities? Explain "lessons learned" from this case study, including how you might apply this case to your own practice when providing care to patients with similar clinical presentations References Drugs.com (2017). Venlafaxine. Retrieved from https://www.drugs.com/pro/venlafaxine.html Gibiino, S., Marsano, A., & Serretti, A. (2014). Specificity profile of venlafaxine and sertraline in major depression: Metaregression of double-blind, randomized clinical trials. International Journal of Neuropsychopharmacology, 17(1), 1-8. https://doiorg.ezp.waldenulibrary.org/10.1017/S1461145713000746 Hage, M. P., & Azar, S. T. (2012). The Link between Thyroid Function and Depression. Journal of Thyroid Research, 2012, 590648. http://doi.org/10.1155/2012/590648 Lehrman, P. M. (2017, August 14). Depression and Elevated Liver Enzymes. Retrieved June 13, 2018, from https://www.livestrong.com/article/545734-depression-elevated-liver-enzymes/ Mayo Clinic. (2018). Cytochrome P450 (CYP450) tests. Retrieved from https://www.mayoclinic.org/tests-procedures/cyp450-test/about/pac-20393711 Nauert, R. (2017). Blood Test Can Help Determine Best Medication for Depression. Psych Central. Retrieved on June 13, 2018, from https://psychcentral.com/news/2017/03/31/blood-test-can-help-determine-best-medication-for-depression/118440.html National Institute of Mental Health (2017). Persistent Depressive Disorder (Dysthymic Disorder). Retrieved from https://www.nimh.nih.gov/health/statistics/persistent-depressive-disorder-dysthymic-disorder.shtml Sansone, R. A., & Sansone, L. A. (2012). Antidepressant adherence: Are patients taking their medications? Innovations in Clinical Neuroscience, 9(5-6), 41-46. Retrieved from the Walden University databases. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press. Stahl, S. M. (2014b). The prescriber's guide (5th ed.). New York, NY: Cambridge University Press. Uher, R., Payne, J. L., Pavlova, B., & Perlis, R. H. (2014). Major Depressive Disorder in Dsm-5: Implications for Clinical Practice and Research of Changes from Dsm-Iv. DEPRESSION AND ANXIETY, 31(6), 459-471. https://doi-org.ezp.waldenulibrary.org/10.1002/da.22217 [Show More]

Last updated: 1 year ago

Preview 1 out of 6 pages